Professional services to design and build a real-time cellular thermal shift assay (RT-CETSA) instrument. This is a covid-19 action.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00675
- Awardee
-
Arimation LLC UEI YGP8A9AX4Z23
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $549,920
Award facts
- Opportunity
-
- A real-time cellular thermal shift assay (RT-CETSA) instrument that can perform luminescent reads to monitor target engagement at high temperatures. This is a COVID-19 action. Solicitation · 75N95022Q00561 · Posted Sep 2, 2022
- Contract value 100% obligated
- $549,920.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- Maple Grove, MN 55369, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $50,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $499,920 |
About this award
This is a $549,920 time-and-materials contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Arimation LLC, a small disadvantaged business, to design and build a real-time cellular thermal shift assay (RT-CETSA) instrument. The instrument will support drug discovery efforts through the Antiviral Program for Pandemics to develop treatments for COVID-19 and other coronaviruses. The contract has a 12-month period of performance and is not set aside for small businesses. Arimation LLC has prior experience providing specialized automation and robotics services to NCATS.
Quick answers
Who was awarded contract 75N95022P00675?
75N95022P00675 was awarded to Arimation LLC by National Institute on Drug Abuse (National Institutes of Health) on September 19, 2022.
How much is contract 75N95022P00675 worth?
The government has obligated $549,920 on 75N95022P00675.
Which agency awarded contract 75N95022P00675?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00675, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00675 competed?
The extent of competition for 75N95022P00675 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award